| Metric | FY 2025↕ |
|---|---|
| Revenue | $5.1B |
| Cost of Revenue | $1.5B |
| Gross Profit | — |
| R&D Expense | $0.4B |
| SG&A Expense | — |
| Operating Income | $-0.0B |
| Net Income | $-1.2B |
| EPS (Basic) | $-2.75 |
| EPS (Diluted) | $-2.81 |
| Metric | FY 2025↕ |
|---|---|
| Total Assets | $49.3B |
| Current Assets | $7.5B |
| Cash & Equivalents | $3.1B |
| Total Liabilities | $46.0B |
| Current Liabilities | $16.4B |
| Stockholders' Equity | $3.3B |
| Metric | FY 2025↕ |
|---|---|
| Operating Cash Flow | $3.1B |
| Investing Cash Flow | $-10.3B |
| Capital Expenditures | $10.3B |
| Financing Cash Flow | $9.3B |